Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma.

MLA

Dong, Lin, et al. “Targeting STAT3 Potentiates CDK4/6 Inhibitors Therapy in Head and Neck Squamous Cell Carcinoma.” Cancer Letters, vol. 593, July 2024, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.canlet.2024.216956.

APA

Dong, L., Liu, C., Sun, H., Wang, M., Sun, M., Zheng, J., Yu, X., Shi, R., Wang, B., Zhou, Q., Chen, Z., Xing, B., Wang, Y., Yao, X., Mei, M., Ren, Y., & Zhou, X. (2024). Targeting STAT3 potentiates CDK4/6 inhibitors therapy in head and neck squamous cell carcinoma. Cancer Letters, 593, N.PAG. https://doi.org/10.1016/j.canlet.2024.216956

Chicago

Dong, Lin, Chao Liu, Haoyang Sun, Mo Wang, Mengyu Sun, Jianwei Zheng, Xiaoxue Yu, et al. 2024. “Targeting STAT3 Potentiates CDK4/6 Inhibitors Therapy in Head and Neck Squamous Cell Carcinoma.” Cancer Letters 593 (July): N.PAG. doi:10.1016/j.canlet.2024.216956.